EGFR and cancer: The results revealed that 69 pathways were significantly enriched in the high-risk group, including those related to axon guidance, progesterone-mediated oocyte maturation, cancer, ErbB signaling, DNA replication, EC, MAPK, and the cell cycle (false discovery rate: q<0.05) (Table 3).